EVP, CFO and Sec. of Chemocentryx Inc (30-Year Financial, Insider Trades) Susan M Kanaya (insider trades) sold 62,998 shares of CCXI on 01/17/2020 at an average price of $41 a share. The total sale was $2.6 million.
ChemoCentryx Inc is a biopharmaceutical company. It is engaged in discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ChemoCentryx Inc has a market cap of $2.54 billion; its shares were traded at around $43.66 with and P/S ratio of 67.18. GuruFocus has detected 1 severe warning sign with ChemoCentryx Inc. .
CEO Recent Trades:
- President and CEO Thomas J. Schall sold 136,052 shares of CCXI stock on 01/17/2020 at the average price of $41.47. The price of the stock has increased by 5.28% since.
CFO Recent Trades:
- EVP, CFO and Sec. Susan M Kanaya sold 62,998 shares of CCXI stock on 01/17/2020 at the average price of $41. The price of the stock has increased by 6.49% since.
Directors and Officers Recent Trades:
- Chief Bus. Officer & Treasurer Markus J. Cappel sold 50,000 shares of CCXI stock on 01/16/2020 at the average price of $40.07. The price of the stock has increased by 8.96% since.
- Principal Acctg Officer Pui San Kwan sold 89,179 shares of CCXI stock on 01/16/2020 at the average price of $39.91. The price of the stock has increased by 9.4% since.
- Chief Bus. Officer & Treasurer Markus J. Cappel sold 116,456 shares of CCXI stock on 01/14/2020 at the average price of $37.27. The price of the stock has increased by 17.15% since.
- Director James L Tyree sold 30,000 shares of CCXI stock on 01/13/2020 at the average price of $37.06. The price of the stock has increased by 17.81% since.
- Principal Acctg Officer Pui San Kwan sold 1,000 shares of CCXI stock on 01/10/2020 at the average price of $39.02. The price of the stock has increased by 11.89% since.
For the complete insider trading history of CCXI, click here
.
